From Our 2009 Archives
Alimta Approved as Maintenance Therapy for Advanced Lung Cancer
Latest Cancer News
MONDAY, July 6 (HealthDay News) -- The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.
The drug is produced by Indianpolis-based Eli Lilly & Co.
-- Scott Roberts
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Get the latest health and medical information delivered direct to your inbox FREE!